Socio-demographic characteristics of people who died from pulmonary tuberculosis in the state of Veracruz, Mexico, 1993;Características Sociodemográficas de personas que murieron por tuberculosis pulmonar en Veracruz, México, 1993

Salud Publica de Mexico

Volumn 38, Issue 5, 1996, Pages 323-331

  Bustamante Montes, Lilia Patricia ^a   Bellido Bárcenas, Francisco ^b   Riojas Rodríguez, Horacio ^a   Borja Aburto, Víctor Hugo ^a   Yáñez Velasco, Lucía ^c   Becerra Posada, Francisco ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b Servicios Coordinados Salud PEV   (Mexico)

^c SECRETARÍA DE SALUD   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; HUMAN; LUNG TUBERCULOSIS; MALE; MEXICO; MIDDLE AGED; SOCIOECONOMICS;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; MALE; MEXICO; MIDDLE AGED; SOCIOECONOMIC FACTORS; TUBERCULOSIS, PULMONARY;

EID: 2742591322     PISSN: 00363634     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. World Health Organization. Fact Sheet No. 104, revised. Ginebra: World Health Organization Press Office, 1996.
2. McSherry G, Connor E. Current epidemiology of tuberculosis. Pediatr Ann 1993;22(10):600-604.
3. García ML, Valdespino JL, García-Sancho C, Salcedo RA, Zacarías F, Sepúlveda J. Epidemiología del SIDA y la tuberculosis. Bol Oficina Sanit Panam 1994;116(6): 546-561.
4. World Health Organization. Fact Sheet No 93. Ginebra: World Health Organization Press Office, 1995.
5. Mercado-Martínez FJ, Gloyd S, Durning J, López-López JL, Barrera-Sánchez FJ. Riesgo de infección por tuberculosis en las jurisdicciones sanitarias de Jalisco, México. Salud Publica Mex 1992;34(5):499-505.
6. Organización Mundial de la Salud. IX Clasificación Internacional de Enfermedades. México: Secretaría de Salud, 1986.
7. Secretaría de Salud. Mortalidad 1993. México: Subsecretaría de Planeación, SSA, 1994.
8. Barry J. "Avoidable mortality" as an index of health care outcome: Results from the European Community Atlas of "Avoidable Death". Ir J Med Sci 1992;161(8):490-492.
9. Bovbjerg RR. The importance of public health for twentyfirst-century health care: Lessons from tuberculosis. J Health Polit Policy Law 1994;19(1):155-163.
10. Molina-Gamboa JD, Ponce de León S, Sifuentes-Osornio J, Bobadilla-del Valle M, Ruiz-Palatios GM. Mycobacterium infection in Mexican AIDS patients. J Acquir Immune Defic Syndr Hum Retrovirol 1995;11(1):53-58.
11. Manjarrez-Morales EM, Serrano-Montes V, Cano-Pérez G, Verduzco-Guerrero E, Escandón-Romero C, Escobedo-de la Peña J. Principales causas de abandono de tratamiento contra la tuberculosis pulmonar. Gac Med Mex 1993;129(1):57-62.
12. Centers for Disease Control and Prevention. Approaches to improving adherence to antituberculosis therapy-South Carolina and New York, 1986-1991. MMWR Morb Mortal Wkly Rep 1993;42(4):74-75.
13. Sifuentes-Osornio J, Ponce de León LA, Camacho-Mezquita FE, Bobadilla-del Valle JM, Infante-Suárez ML, Ramírez-Fernández N. Resistencia de Mycobacterium tuberculosis en pacientes mexicanos. I. Características clínicas y factores de riesgo. Rev Invest Clin 1995;47(4):273-281.
14. Yew WW. Drug resistant tuberculosis in the 1990s. Eur Respir J 1995;8(7):1184-1192.
15. Morris JT, Seaworth BJ, McAllister CK. Pulmonary tuberculosis in diabetics. Chest 1992;102(2):539-541.
16. Weis SE, Slocum PC, Blais FX, King B, Nunn M, Matney GB et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994;330(7):1179-1184.
17. Freudenberg N. A new role for community organizations in the prevention and control of tuberculosis. J Community Health 1995;20(1):15-28.